𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adjuvant and extended adjuvant use of aromatase inhibitors: Reducing the risk of recurrence and distant metastasis

✍ Scribed by Joseph Gligorov; Kathleen Pritchard; Paul Goss


Book ID
113506967
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
217 KB
Volume
16
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Do adjuvant aromatase inhibitors increas
✍ Federica Cuppone; Emilio Bria; Sunil Verma; Kathleen I. Pritchard; Sonal Gandhi; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 203 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada‐Common Toxicity Criteria [version